Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - l-leucine; l-phenylalanine; l-methionine; l-lysine; l-isoleucine; l-valine; l-histidine; l-threonine; l-tryptophan; l-alanine; l-arginine; glycine; l-proline; l-serine; l-tyrosine; sodium acetate trihydrate ; dibasic potassium phosphate ; sodium chloride; magnesium chloride hexahydrate; glucose; calcium chloride dihydrate - solution for infusion - solutions for parenteral nutrition; amino acids

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline south africa ltd. - albendazole - tablets - 400mg

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - raltegravir potassium -

Malta - English - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - vancomycin hydrochloride - powder for concentrate for solution for infusion - vancomycin hydrochloride 500 mg - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - secukinumab 150mg;   - powder for injection - 150 mg - active: secukinumab 150mg   excipient: histidine hydrochloride monohydrate nitrogen polysorbate 80 sucrose - cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - secukinumab 150 mg/ml;   - solution for injection - 150 mg/ml - active: secukinumab 150 mg/ml   excipient: histidine hydrochloride monohydrate methionine nitrogen polysorbate 80 trehalose dihydrate water for injection - cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 25mg - eltrombopag (eltrombopag olamine) 25mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 50mg - eltrombopag (eltrombopag olamine) 50mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 75mg - eltrombopag (eltrombopag olamine) 75mg - hematopoietic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - eltrombopag (eltrombopag olamine) - tablet - 12.5mg - eltrombopag (eltrombopag olamine) 12.5mg - hematopoietic agents